126 related articles for article (PubMed ID: 23590894)
1. Progressive supranuclear palsy phenotype mimicking synucleinopathies.
Menšíková K; Matěj R; Tučková L; Rusina R; Ehrmann J; Kaňovský P
J Neurol Sci; 2013 Jun; 329(1-2):34-7. PubMed ID: 23590894
[TBL] [Abstract][Full Text] [Related]
2. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
Cordato NJ; Halliday GM; Harding AJ; Hely MA; Morris JG
Ann Neurol; 2000 Jun; 47(6):718-28. PubMed ID: 10852537
[TBL] [Abstract][Full Text] [Related]
3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
4. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
[TBL] [Abstract][Full Text] [Related]
5. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
Miki Y; Foti SC; Asi YT; Tsushima E; Quinn N; Ling H; Holton JL
Brain; 2019 Sep; 142(9):2813-2827. PubMed ID: 31289815
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
[TBL] [Abstract][Full Text] [Related]
7. Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration.
Mark MH
Neurol Clin; 2001 Aug; 19(3):607-27, vi. PubMed ID: 11532646
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic criteria of parkinsonian syndromes].
Tison F
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
[TBL] [Abstract][Full Text] [Related]
9. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
13. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
[TBL] [Abstract][Full Text] [Related]
14. ["Red flags": when to be alerted and how to explore?].
Tison F
Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230
[TBL] [Abstract][Full Text] [Related]
15. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
16. A differential diagnosis of Parkinsonism.
Weiner WJ
Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
Wenning GK; Colosimo C
Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
[TBL] [Abstract][Full Text] [Related]
18. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
[TBL] [Abstract][Full Text] [Related]
19. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
[TBL] [Abstract][Full Text] [Related]
20. Assessing disease progression with MRI in atypical parkinsonian disorders.
Köllensperger M; Wenning GK
Mov Disord; 2009; 24 Suppl 2():S699-702. PubMed ID: 19877233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
